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Abstract
Introduction: Merkel cell carcinoma and dermatofibrosarcoma protuberans are two very rare
neoplasms. The simultaneous occurrence of two different tumour entities at the same anatomical
site, collision tumours, is a rare phenomenon.
Case presentation: We present a rare case of a 74-year-old woman with a previous history of a
recurrent dermatofibrosarcoma protuberans presenting with a metastatic Merkel cell carcinoma.
Further investigation revealed a collision tumour of a metastatic lesion of the Merkel cell carcinoma
within a tumour relapse of a dermatofibrosarcoma protuberans.
Conclusion: Synchronous occurrence of two different tumour entities is extremely rare and has
not been described for Merkel cell carcinoma and dermatofibrosarcoma. Merkel cell carcinoma, a
tumour of the elderly or immunocompromised patients, leads to early metastasis and can be
expected to be the limiting factor for prognoses.
Introduction
Primary neuroendocrine tumour of the skin, also known
as Merkel cell carcinoma (MCC), was first described by
Toker in 1972. It is a rare but aggressive tumour entity of
sun-exposed skin of the elderly in the age range of 60 to
90 years. The origin of this tumour is thought to be a
line of differentiation according to Merkel cells. Under
homeostatic conditions, the Merkel cells, discovered by
Friedrich Merkel in 1875, are normal constituents of the
basal layer of the epidermis and hair follicles. A higher
density of Merkel cells is found in the glabrous epithelium
of the digits, lips and oral cavity and hair bearing skin.
They represent slow acting mechano-receptors with close
contact to unmyelinated nervous fibres in the superficial
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epidermal-ectodermal nature is still unclear.
MCC, with a female predominance, [1] has a predilection
for the head and neck region, a potential for early
metastasis and is rarely encountered on the extremities
and trunk. Conditions leading to impaired immunity,
such as immunosuppression therapy [2], human immu-
nodeficiency virus infection and chronic lymphocytic
leukaemia have been associated with a higher incidence
of MCC.
Dermatofibrosarcoma protuberans (DFSP) is another
uncommon skin malignancy. As an intermediate neo-
plasm it has a local aggressive growth pattern but it rarely
metastasizes. In the uncommon event of metastasis they
are often found in the lungs and in the lymph nodes [3]. A
high recurrence rate complicates the course of the disease
and requires wide local excision with clear margins.
Clinically, DFSP often presents as slow growing nodular
masses of the skin on the trunk or proximal extremities.
Simultaneous occurrence of two different tumour entities
at the same anatomical site is a very rare event. Cases of
haematopoietic neoplasms in association with breast and
skin malignancies have been reported. To our knowledge
this is the first reported case of a synchronous occurrence
(collision tumour) of MCC and DFSP.
Case presentation
A 74-year-old, Caucasian woman from Germany with a
longhistoryoflocalrecurrencesofDFSPonherrightupper
limb was readmitted for surgical intervention of a tumour
of her right axilla. On clinical examination she presented
with two firm tumour masses in the right axilla and on the
thoracic wall with a size of 6 × 7 cm and 6 × 5 cm. Both
lesions displayed central ulceration. In addition, the
patient requested the resection of a small (1.7 × 1.6 cm)
nodular skin lesion of her right elbow region.
The DFSP of her right shoulder region was first diagnosed
in 1991. Following several incomplete tumour resections
and local progressive tumour growth she was transferred
to our hospital in 2001. Tumour resection was carried out
and radiation therapy was suggested but refused by the
patient. Despite clear resection margins the tumour
recurred locally 10 months later and, at this stage, the
tumour had infiltrated the brachial plexus. Since then,
additional surgical interventions for local recurrences of
the DFSP were required every 5 to 9 months. Fifteen years
after the initial diagnosis of the DFSP, at readmission for a
local recurrence, the tumour extended from the axilla
along the thoracic wall to the lateral aspect of the
ipsilateral scapular and an additional small (less than
2 cm) reddish blue subcutaneous nodular lesion was
observed at the dorsal aspect of the right elbow.
Histologically the two tumour masses in the axilla and
thoracic wall confirmed the clinical diagnosis of a local
recurrence of the known DFSP. The tumours were highly
cellular with partly ovoid, partly spindle shaped nuclei
with small fascicular cell formations. Due to these clear
detectable fascicular areas, these recurrences were classified
as DFSP with fibrosarcomatous transformation (Figure 1).
In contrast, the tumour from the elbow microscopically
presented as a highly cellular small cell tumour lacking
fascicular formations (Figure 2). Additional immunohis-
tochemical analysis revealed punctual reaction of the vast
majority of tumour cells for keratin MNF 116 with a
cytoplasmatic distribution and a punctual perinuclear
immune reaction for cytokeratin-20. The tumour was
CD3, CD20 and LCA negative. A high proliferative activity
index (Ki 67) of 70% was evident. The histological and
immunohistochemical analysis verified the diagnosis of a
Merkel cell carcinoma (pT1 pN0,p M 0 R0).
The Merkel cell carcinoma was resected in total whereas a
complete resection of the DFSP (pT2b,p N 0,p M 0,R 2) with
preservation of the extremity could not be achieved.
S i xm o n t h sa f t e rt h es u r g e r yt h ep a t i e n ts u f f e r e da
synchronous local recurrence of both the DFSP and
MCC (Figure 3). At this time the tumour specimen from
the elbow histologically resembled the previously
described MCC. The axillary specimen revealed an
Figure 1. Haematoxylin and eosin stain of the axillary
tumour. Note the characteristic partial storiform, partial
fascicular, growth of the dermatofibrosarcoma protuberans.
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storiform, partial fascicular, growth pattern. Within this
tumour, an area of up to 1.1 cm with a small cell tumour
infiltrate, correlating with the described Merkel cell
tumour mixed with a spindle cell tumour formation, was
found. The histological findings displayed a collision
tumour of a metastasis of the Merkel cell tumour (pT3,
pN0,p M 1) and the relapse tumour of DFSP (pT2b,p N 0,
pM0, R2) (Figure 4). Further clinical and radiological
tumour staging demonstrated no further evidence of
metastatic disease.
For local tumour control, the option of an interthoracos-
capular amputation was discussed but not accepted by the
patient. Therefore, palliative radiotherapy and chemother-
apy with the tyrosine kinase inhibitor Imatinib was
initiated.
Discussion
Both DFSP and MCC are very rare malignancies. Even
though the occurrence of multiple malignancies in the
same anatomical site in organs such as the thyroid, breast
and lymph nodes [4] have been described previously,
the occurrence of synchronous colliding tumours
remains an extremely uncommon condition with a very
limited number of cases in the literature. Single cases
of the simultaneous appearance of MCC with chronic
lymphatic leukaemia [5] or rhabdomyosarcoma [6] have
been described. To our knowledge this is the first reported
case involving MCC and DFSP; in this patient, a
haematogenous metastasis of a MCC within a relapse
tumour of DFSP located in the axilla.
Even though the association between these two tumours
in our patient is most likely coincidental, immunosup-
pression during a long course of previous tumour disease
of the right upper extremity might be accountable for an
increased risk of developing a secondary malignancy such
as the MCC.
Clinical studies and animal experiments demonstrate the
fact that malignant tumours lead to an altered immune
status systemically, as well as locally, through changes
in the microenvironment. Functional impairment of
T-lymphocytes in addition to an accumulation of chroni-
cally activated myeloid suppressor cells and regulatory
T-cells has been observed systemically. This may lead to a
disabled tumour killing CD 8 CTL response and enhance
cancer development through activation of other immune
cells.
Figure 3. Clinical presentation of the collision tumour
relapse of the dermatofibrosarcoma protuberans and
metastatic lesion of the Merkel cell carcinoma of the axilla.
Figure 2. Haematoxylin and eosin stain of the tumour of the
elbow region. Note the small cell characteristic of the Merkel
cell carcinoma.
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increase in certain pro-inflammatory cytokines and pro-
angiogenic mediators such as interleukin 1 and 6 (IL1,
IL6) tumour necrosis factor (TNF a) and vascular
endothelial growth factor (VEGF), is one mechanism by
which the tumour infiltrating leucocytes promote tumour
growth, cell survival and an increase in tumour angiogen-
esis [7,8].
Many studies have confirmed an increase in certain matrix
metalloproteinases (MMPs) altering tissue homeostasis
through various biological pathways such as remodelling
of the extracellular matrices, increase in cell-cell and cell-
matrix adhesion molecules and thereby altering intracel-
lular signalling pathways and often correlating with a
poorer prognosis. But many of the mechanisms involved
in tumour immunology and tumorigenesis, differentia-
tion and dedifferentiation of cancer stem cells are still
unknown, especially mechanisms involved in the syn-
chronous appearance of malignant tumours [9].
For both malignancies described here, surgical resection of
the tumour with clear surgical margins is the main choice
of treatment. Both tumours are very rare neoplasms with a
similar incidence of four cases or less per million per year.
DFSP may affect patients of all ages but is rarely
encountered during childhood and it mainly occurs in
adults between 20 and 40 years of age. It is a tumour of the
dermis and subcutis characterized by a local aggressive
growth pattern. Its asymmetric growth and pseudopod-
like extensions aggravate tumour resection and account for
a high rate of local recurrence of up 60% [10]. A strong
correlation between surgical margins and tumour free
survival has been demonstrated. Invasion of the under-
lying fascia and muscle has been observed in patients with
a long history of DFSP. In these cases wide local resection
may be mutilating and in this case an interthoracoscapular
resection would have been required. Fibrosarcomatous
transformation of DFSP results in an increased risk of
distant metastasis especially into the lungs and an even
higher rate of local recurrence [11,12].
Radiotherapy has been successful in gaining local tumour
control. DFSP has been found to be non-chemotherapy
sensitive. Recently the tyrosine kinase inhibitor Imatinib
has demonstrated an antitumorigenic effect with promis-
ing results for patients with metastatic disease as well as for
local tumour control [13]. MCC on the other hand is a
cutaneous small cell carcinoma of the elderly with a
female predominance [1]. Impaired immune status due to
viral infections or immunosuppression therapy has been
linked to an increased risk of developing MCC [5]. In the
case described here the patient had no history of
immunosuppressive therapy and displayed no reasonable
grounds to suspect HIV infection even though this was not
confirmed by laboratory testing.
In the last 7 years, 12 patients with a MCC were treated in
our clinic. Interestingly, four of these 12 patients had a
history of an underlying previous malignancy and one
additional patient suffered from chronic renalfailure. Both
conditions possibly lead to a compromised immune
response. Compared to other extra pulmonary small cell
cancers MCC appears to have a favourable prognosis but it
remains an aggressive tumour with a frequent recurrence,
early metastases and high mortality rates. In contrast to
melanoma, which also represents a neuroendocrine
tumour of the skin, tumour thickness seemingly is of no
prognostic value. Regional lymph node status appears to
influence local recurrence but not the overall prognosis
[14]. MCC has the potential for haematogenous metastasis
mainly affecting the lungs as well as lymphatic metastasis.
Distant metastasis is the limiting prognostic factor. Similar
to other small cell carcinomas radiotherapy and che-
motherapy sensitivity has been described. Various clinical
and histological parameters have been evaluated regarding
their predictive prognostic value but findings remain
contradictory [15].
Conclusions
Both MCC and DFSP are uncommon tumour entities
of elderly or immunocompromised patients. Collision
tumours are extremely rare and have never been described
for MCC and DFSP. In this patient the distant metastasis of
the MCC is expected to be the limiting factor for survival.
Figure 4. Haematoxylin and eosin stain of the collision
tumour of the metastatic Merkel cell tumour within the
tumour relapse of the dermatofibrosarcoma protuberans.
Note the coexistence of a small cell tumour mass within a
storiform, fascicular cell formation.
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